Rapid eye movement sleep behaviour disorder and Parkinson's disease

Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during the REM phase of sleep, leading to the enactment of dreams. This can result in movements, vocalizations, and even violent behavior during sleep. Research has shown a strong association between RBD and the development of neurodegenerative disorders, particularly Parkinson's disease.

Overview of RBD

RBD typically involves the following symptoms:

• Vocalizations, such as talking, shouting, or screaming during sleep
• Movements or complex motor behaviors, including kicking, punching, or running
• Dream-enacting behaviors that can potentially cause injury to oneself or bed partner
• Abrupt awakenings with vivid dream recall
• These behaviors occur during the REM stage of sleep, when the body is typically in a state of muscle atonia or paralysis, preventing dream enactment.

RBD and Parkinson's Disease

Several studies have found a significant link between RBD and the development of Parkinson's disease, a neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. Some key points about this relationship include:

• High conversion rate: It is estimated that up to 80% of individuals with idiopathic RBD (i.e., RBD without a known cause) may eventually develop Parkinson's disease or other synucleinopathies, such as dementia with Lewy bodies or multiple system atrophy.
• Early warning sign: RBD can precede the onset of motor symptoms of Parkinson's disease by several years or even decades, making it a potential early biomarker for the disease.
• Shared pathology: Both RBD and Parkinson's disease share a common pathological feature, which is the accumulation of alpha-synuclein protein in the brain. This protein forms aggregates called Lewy bodies, which are found in the affected brain regions of people with Parkinson's disease and some cases of RBD.

Diagnosis and Treatment

Diagnosis of RBD typically involves a clinical evaluation, a detailed sleep history, and an overnight sleep study called polysomnography to confirm the presence of REM sleep without atonia. In the context of Parkinson's disease, RBD may be diagnosed in conjunction with the motor symptoms and other clinical features of the disease.

Treatment for RBD often includes:

• Clonazepam: This benzodiazepine medication is often prescribed as a first-line treatment for RBD, as it has been shown to be effective in reducing the frequency and severity of RBD episodes.
• Melatonin: Some patients with RBD may benefit from taking melatonin, a natural hormone involved in sleep regulation.
• Environmental modifications: Ensuring a safe sleep environment by padding the bed, removing sharp objects, and placing a protective barrier around the bed can help prevent injury during RBD episodes.
• It is crucial for individuals with RBD to be closely monitored for the potential development of Parkinson's disease or other neurodegenerative disorders. Early diagnosis and intervention can help improve the quality of life for those affected by these conditions.

Rapid eye movement sleep behaviour disorder and Parkinson's disease Resources
Latest articles Most recent articles Ongoing trials	Wikipedia